Confirmation of a Rare Genetic Leukoencephalopathy due to a Novel Bi-allelic Variant in RPIA

  • Parneet Kaur
  • , Mirjam M.C. Wamelink
  • , Marjo S. van der Knaap
  • , Katta Mohan Girisha
  • , Anju Shukla*
  • *Corresponding author for this work

Research output: Contribution to journalArticlepeer-review

10 Citations (Scopus)

Abstract

Ribose 5-phosphate isomerase deficiency is a rare genetic leukoencephalopathy caused by pathogenic sequence variants in RPIA, that encodes ribose 5-phosphate isomerase, an enzyme in the pentose phosphate pathway. Till date, only three individuals with ribose 5-phosphate isomerase deficiency have been described in literature. We report on a subject with RPIA associated progressive leukoencephalopathy with elevated urine arabitol and ribitol levels and a novel missense variant c.770T > C p.(Ile257Thr) in exon 8 of RPIA. We also compare the phenotypes of all the four subjects. Our report confirms the phenotype and the genetic cause of this condition.

Original languageEnglish
Article number103708
JournalEuropean Journal of Medical Genetics
Volume62
Issue number8
DOIs
Publication statusPublished - 01-08-2019

All Science Journal Classification (ASJC) codes

  • Genetics
  • Genetics(clinical)

Fingerprint

Dive into the research topics of 'Confirmation of a Rare Genetic Leukoencephalopathy due to a Novel Bi-allelic Variant in RPIA'. Together they form a unique fingerprint.

Cite this